JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB120382

Z-VAD(OH)-FMK, Irreversible general caspase inhibitor

Be the first to review this product! Submit a review

|

(24 Publications)

MW 453.5 Da, Purity >94%. Achieve your results faster with highly validated, pure and trusted compounds.
3 Images
Immunoprecipitation - Z-VAD(OH)-FMK, Irreversible general caspase inhibitor (AB120382)
  • IP

Lab

Immunoprecipitation - Z-VAD(OH)-FMK, Irreversible general caspase inhibitor (AB120382)

MLKL (phospho S345) was immunoprecipitated from 1mg of L-929 (Mouse connective tissue fibroblast cells) whole cell lysate treated with 20 ng/ml TNF alpha (ab9642) + 100 nM Smac mimetic + 20 μM z-VAD compound (ab120382) for 8h using ab196436 at 1/150 dilution. Western blot was performed from the immunoprecipitate using ab196436 at 1/1000 dilution. Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG, was used as secondary antibody at 1/1500 dilution.

Lane 1 : L-929 whole cell lysate treated with 20 ng/ml TNF alpha (ab9642) + 100 nM Smac mimetic+ 20 μM z-VAD compound (ab120382) for 8h;10 μg (Input).
Lane 2 : ab196436 IP in L-929 whole cell lysate treated with 20 ng/ml TNF alpha (ab9642) + 100 nM Smac mimetic+ 20 μM z-VAD compound (ab120382) for 8h.
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab196436 in L-929 whole cell lysate treated with 20 ng/ml TNF alpha (ab9642) + 100 nM Smac mimetic+ 20 μM z-VAD compound (ab120382) for 8h.

Blocking and dilution buffer and concentration : 5% NFDM/TBST.

All lanes:

Immunoprecipitation - Anti-MLKL (phospho S345) antibody [EPR9515(2)] (<a href='/en-us/products/primary-antibodies/mlkl-phospho-s345-antibody-epr95152-ab196436'>ab196436</a>)

All lanes:

Immunoprecipitation - Recombinant human TNF alpha protein (<a href='/en-us/products/proteins-peptides/recombinant-human-tnf-alpha-protein-ab9642'>ab9642</a>)

Predicted band size: 54 kDa

Observed band size: 54 kDa

false

Functional Studies - Z-VAD(OH)-FMK, Irreversible general caspase inhibitor (AB120382)
  • FuncS

PubMed

Functional Studies - Z-VAD(OH)-FMK, Irreversible general caspase inhibitor (AB120382)

ZVAD-fmk treatment does not correct muscular dystrophy in Nol3-/-Sgcd-/- mice.

A : Muscle weights normalized to tibial length of quadriceps of mice treated with or without ZVAD-fmk for 4 weeks

B : Creatine Kinase levels

C : Quantification of the time to exhaustion as assessed by involuntary treadmill running measured from vehicle or ZVAD-fmk treated WT and Nol3-/- Sgcd-/- mice

D : Histologic images taken at 100x of Masson's trichrome stained sections of quadriceps from vehicle or ZVAD-fmk treated WT and Nol3-/-Sgcd-/- mice

Davis J et al. PLoS One. 2013; 8(12) : e82053. doi : 10.1371/journal.pone.0082053

Davis J et al. PLoS One. 2013; 8(12): e82053. doi: 10.1371/journal.pone.0082053 Reproduced under the Creative Commons license http://creativecommons.org/licenses/by/4.0/

Chemical Structure - Z-VAD(OH)-FMK, Irreversible general caspase inhibitor (AB120382)
  • Chemical Structure

Lab

Chemical Structure - Z-VAD(OH)-FMK, Irreversible general caspase inhibitor (AB120382)

2D chemical structure image of ab120382, Z-VAD(OH)-FMK, Irreversible general caspase inhibitor

Key facts

CAS number

220644-02-0

Purity

>94%

Form

Solid

form

Molecular weight

453.5 Da

Molecular formula

C<sub>2</sub><sub>1</sub>H<sub>2</sub><sub>8</sub>FN<sub>3</sub>O<sub>7</sub>

PubChem

5497170

Nature

Synthetic

Solubility

Soluble in DMSO to 20 mM

Biochemical name

benzyloxycarbonyl-Val-Ala-DL-Asp-fluoromethylketone

Canonical smiles

CC(C)C(C(=O)NC(C)C(=O)NC(CC(=O)O)C(=O)CF)NC(=O)OCC1=CC=CC=C1

Isomeric smiles

C[C@@H](C(=O)NC(CC(=O)O)C(=O)CF)NC(=O)[C@H](C(C)C)NC(=O)OCC1=CC=CC=C1

InChi

InChI=1S/C21H28FN3O7/c1-12(2)18(25-21(31)32-11-14-7-5-4-6-8-14)20(30)23-13(3)19(29)24-15(9-17(27)28)16(26)10-22/h4-8,12-13,15,18H,9-11H2,1-3H3,(H,23,30)(H,24,29)(H,25,31)(H,27,28)/t13-,15?,18-/m0/s1

InChiKey

SUUHZYLYARUNIA-LWSHRDBSSA-N

IUPAC Name

5-fluoro-3-[[(2S)-2-[[(2S)-3-methyl-2-(phenylmethoxycarbonylamino)butanoyl]amino]propanoyl]amino]-4-oxopentanoic acid

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Storage information
Store under desiccating conditions|The product can be stored for up to 12 months

Product protocols

Publications (24)

Recent publications for all applications. Explore the full list and refine your search

Nature communications 15:3816 PubMed38769293

2024

Fatal COVID-19 pulmonary disease involves ferroptosis.

Applications

Unspecified application

Species

Unspecified reactive species

Baiyu Qiu,Fereshteh Zandkarimi,Anjali Saqi,Candace Castagna,Hui Tan,Miroslav Sekulic,Lisa Miorin,Hanina Hibshoosh,Shinya Toyokuni,Koji Uchida,Brent R Stockwell

Molecular and cellular biochemistry 477:2213-2233 PubMed35460011

2022

Energetic metabolic reprogramming in Jurkat DFF40-deficient cancer cells.

Applications

Unspecified application

Species

Unspecified reactive species

Merve Kulbay,Bruno Johnson,Guillaume Ricaud,Marie-Noëlle Séguin-Grignon,Jacques Bernier

Cell death and differentiation 29:492-503 PubMed34535764

2021

Potent pro-apoptotic combination therapy is highly effective in a broad range of cancers.

Applications

Unspecified application

Species

Unspecified reactive species

Antonella Montinaro,Itziar Areso Zubiaur,Julia Saggau,Anna-Laura Kretz,Rute M M Ferreira,Omar Hassan,Ella Kitzig,Ines Müller,Mona A El-Bahrawy,Silvia von Karstedt,Dagmar Kulms,Gianmaria Liccardi,Johannes Lemke,Henning Walczak

Molecular brain 12:78 PubMed31533781

2019

miR-212-5p attenuates ferroptotic neuronal death after traumatic brain injury by targeting Ptgs2.

Applications

Unspecified application

Species

Unspecified reactive species

Xiao Xiao,Youjing Jiang,Weibo Liang,Yanyun Wang,Shuqiang Cao,He Yan,Linbo Gao,Lin Zhang

Acta pharmacologica Sinica 40:1466-1479 PubMed31316176

2019

WX20120108, a novel IAP antagonist, induces tumor cell autophagy via activating ROS-FOXO pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Rui Ding,Xin Wang,Wei Chen,Zhi Li,Ai-Li Wei,Qing-Bin Wang,Ai-Hua Nie,Li-Li Wang

Nanoscale advances 1:807-816 PubMed36132240

2018

Galactose:PEGamine coated gold nanoparticles adhere to filopodia and cause extrinsic apoptosis.

Applications

Unspecified application

Species

Unspecified reactive species

Konstantina Tzelepi,Cristina Espinosa Garcia,Phil Williams,Jon Golding

Medical science monitor : international medical jo 24:5247-5257 PubMed30057402

2018

Receptor-Interacting Protein 3/Caspase-8 May Regulate Inflammatory Response and Promote Tissue Regeneration in the Periodontal Microenvironment.

Applications

Unspecified application

Species

Unspecified reactive species

Bingbing Yan,Kewen Wei,Lipeng Hou,Taiqiang Dai,Yongchun Gu,Xinyu Qiu,Jiangwei Chen,Yuan Feng,Haode Cheng,Zhuo Yu,Yizhe Zhang,Hongmei Zhang,Dehua Li

Cell death and differentiation 25:1457-1472 PubMed29348676

2018

miR-137 regulates ferroptosis by targeting glutamine transporter SLC1A5 in melanoma.

Applications

Unspecified application

Species

Unspecified reactive species

Meiying Luo,Longfei Wu,Kexin Zhang,Hong Wang,Tian Zhang,Lucas Gutierrez,Douglas O'Connell,Peng Zhang,Yu Li,Tongtong Gao,Wenyan Ren,Yongfei Yang

Journal of virology 92: PubMed29142134

2018

Tumor Necrosis Factor-Mediated Survival of CD169 Cells Promotes Immune Activation during Vesicular Stomatitis Virus Infection.

Applications

Unspecified application

Species

Unspecified reactive species

Prashant V Shinde,Haifeng C Xu,Sathish Kumar Maney,Andreas Kloetgen,Sukumar Namineni,Yuan Zhuang,Nadine Honke,Namir Shaabani,Nicolas Bellora,Mareike Doerrenberg,Mirko Trilling,Vitaly I Pozdeev,Nico van Rooijen,Stefanie Scheu,Klaus Pfeffer,Paul R Crocker,Masato Tanaka,Sujitha Duggimpudi,Percy Knolle,Mathias Heikenwalder,Jürgen Ruland,Tak W Mak,Dirk Brenner,Aleksandra A Pandyra,Jessica I Hoell,Arndt Borkhardt,Dieter Häussinger,Karl S Lang,Philipp A Lang

Journal of the American Heart Association 6: PubMed28971953

2017

Rapamycin and CHIR99021 Coordinate Robust Cardiomyocyte Differentiation From Human Pluripotent Stem Cells Via Reducing p53-Dependent Apoptosis.

Applications

Unspecified application

Species

Human

Xiao-Xu Qiu,Yang Liu,Yi-Fan Zhang,Ya-Na Guan,Qian-Qian Jia,Chen Wang,He Liang,Yong-Qin Li,Huang-Tian Yang,Yong-Wen Qin,Shuang Huang,Xian-Xian Zhao,Qing Jing
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com